AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sopharma AD

Earnings Release Mar 5, 2021

2543_rns_2021-03-05_fe7dcae8-41e7-421a-a6c6-2aac3bb2fc21.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Current report №7/ 2021 Dated March 5, 2021

NOTIFICATION

Sopharma AD notifies that for February 2021 the Company recorded a decrease in sales of 1% compared to the same month of 2020, incl. 34% increase in domestic sales and 12% decrease in export sales.

In the first two months of 2021 the revenues from sales of production increase by 4% compared to the same period of 2020, incl. 27% increase of sales for the domestic market and 4% decrease in export sales.

Signatures of individuals authorized to represent the Company:

Ognian Donev

Talk to a Data Expert

Have a question? We'll get back to you promptly.